Neurodegenerative
- ALS
- Alzheimer’s Disease (AD)
- Dementia
- Parkinson’s Disease (PD)
- Ataxia
Begin with a clear diagnosis and a review of your neurological care. A discussion of emerging research is different from a proven treatment recommendation.

Explore these consultation topics with your provider and existing specialist team. Your diagnosis, history, and personal goals guide the discussion.
Share your neurologist’s assessment, relevant scans or test results, symptom timeline, and current medications. Describe how symptoms affect movement, sensation, memory, or daily activities.
What published evidence applies to my condition? What outcomes were measured? What are the uncertainties, and how will my neurologist help assess the proposal?
FDA’s consumer alert warns that the regenerative products it describes are not approved for neurological disorders. A research finding does not establish that a clinic’s product is effective.
Ask your provider to identify the exact product, intended use, and regulatory status before considering care.
View patient resources ↓A consultation can help clarify what further evaluation or specialist input may be needed. Ask the clinic about availability, consultation fees, and what records to provide. No treatment or outcome is guaranteed.
Find your TNC clinic ↗FDA: Stem cells and exosomes consumer alert ↗
FDA: Exosome safety information ↗
Educational information reviewed October 29, 2026. Discuss your individual circumstances with a qualified provider.